[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-370242-105":59,"doc-detail-370242-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","cdca7-enhances-stat3-transcriptional-activity-to-regulate-aerobic-glycolysis-and-promote-pancreatic-cancer-progression-and-gemcitabine-resistance","CDCA7 enhances STAT3 transcriptional activity to regulate aerobic glycolysis and promote pancreatic cancer progression and gemcitabine resistance","","Cell division cycle associated 7 (CDCA7) is investigated for its role in pancreatic cancer (PC), focusing on how it affects STAT3-driven transcription and metabolic reprogramming. In vitro and in vivo experiments measure CDCA7 expression and functional outcomes through Western blotting, immunohistochemistry, real-time PCR, and assays for proliferation, migration, invasion, and wound healing. CDCA7 overexpression enhances aerobic glycolysis, promoting chemotherapy resistance to gemcitabine. Immunoprecipitation indicates CDCA7 interacts with STAT3 and influences transcriptional regulation of hexokinase 2, suggesting CDCA7 as a therapeutic target to improve gemcitabine sensitivity.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/cdca7-enhances-stat3-transcriptional-activity-to-regulate-aerobic-glycolysis-and-promote-pancreatic-cancer-progression-and-gemcitabine-resistance/370242/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/cdca7-enhances-stat3-transcriptional-activity-to-regulate-aerobic-glycolysis-and-promote-pancreatic-cancer-progression-and-gemcitabine-resistance/370242.png","ImageObject",300,407,{"name":92,"@type":93},"Eliana","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-24","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What question does the study aim to address about CDCA7 in pancreatic cancer?","Question",{"text":112,"@type":113},"It examines CDCA7 expression and its biological functions in pancreatic cancer, particularly whether it contributes to progression and gemcitabine resistance.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How is CDCA7 shown to affect pancreatic cancer cell behavior?",{"text":117,"@type":113},"CDCA7 overexpression promotes proliferation, migration, invasion, and wound healing in pancreatic cancer models.",{"name":119,"@type":110,"acceptedAnswer":120},"What mechanism links CDCA7 to gemcitabine resistance in this research?",{"text":121,"@type":113},"The study reports that CDCA7 increases aerobic glycolysis and interacts with STAT3, affecting transcriptional regulation of hexokinase 2, which may drive gemcitabine resistance.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},370242,1790219330,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":41,"preview_page_count":19,"preview_urls":145},4398048949847,"https://ap-avatar.wpscdn.com/avatar/400002536579ef2da7f?_k=1778318612642679267","[www.nature.com/cddis](www.nature.com/cddis)  \nARTICLE OPEN   \nCDCA7 enhances STAT3 transcriptional activity to regulate aerobic glycolysis and promote pancreatic cancer progression and gemcitabine resistance  \nDijie Zheng 1,2,3,4,7, Yazhu Deng 1,5,7, Lu Deng2,3,4,6,7, Zhiwei He2,3,4,6, Xinghao Sun2,3,4,6, Yanyu Gong2,3,4,6, Binbin Shi2,3,4,6, Deqin Lu1 ✉ and Chao Yu 2,3,4,6 ✉  \n© The Author(s) 2025  \n|  |  |  |\n| --- | --- | --- |\n|  | Cell division cycle associated 7 (CDCA7) plays a role in various malignancies, especially pancreatic cancer (PC) . However, its expression pattern and functional signiﬁcance in PC require further research. Therefore, this study aimed to investigate CDCA7 expression levels and biological functions in PC using in vitro and in vivo experiments. Western blotting, immunohistochemistry, and real-time polymerase chain reaction were performed to detect CDCA7 expression in PC cells and tissues. Additionally, the biological functions of CDCA7 were assessed using cell proliferation, wound healing, and Transwell assays. CDCA7 overexpression promoted PC cell proliferation, migration, and invasion, and increased resistance to the chemotherapy drug gemcitabine, possibly through enhanced aerobic glycolysis. Additionally, immunoprecipitation assay showed that CDCA7 interacted with STAT3 protein and affected the transcriptional regulation of hexokinase 2 . Conclusively, targeting CDCA7 might be a promising therapeutic |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n| strategy to increase gemcitabine sensitivity by inhibiting glycolysis in PC cells. |  |  |\n|  | Cell Death and Disease (2025)16:68; [https://doi.org/10.1038/s41419-025-07399-1](https://doi.org/10.1038/s41419-025-07399-1) |  |\n|  |  |  |\n\nINTRODUCTION  \nPancreatic cancer (PC) remains a serious challenge in oncology due to its high mortality rate, with only a 12% 5-year survival rate [1] . Major contributors to the poor prognosis of PC includedifﬁculties in early detection and limited effectiveness of drug therapies [2] . Notably, due to the limited treatment options for pancreatic cancer, only approximately 20% of patients are eligible for surgical resection [3] . In addition to surgery, chemotherapy isan important treatment strategy for PC. Currently, gemcitabine is the most commonly used drug for PC chemotherapy. However, the efﬁcacy of gemcitabine treatment in PC remains modest, with an overall response rate of less than 20% . Importantly, the low efﬁcacy of gemcitabine is primarily due to the rapid onset of drug resistance in tumor cells, leading to inadequate therapeutic responses [4, 5] . Therefore, it is crucial to investigate the mechanisms underlying PC development and chemotherapy resistance, as well as develop efﬁcacious targeted therapies.  \nCell division cycle associated protein 7 (CDCA7) belongs to the family of cell cycle regulatory proteins. It has been identiﬁed as ac-Myc responsive gene, contributing to MYC-mediated tumorigenesis by acting as a transcriptional regulator [6, 7] . As anoncogenic gene with copy number ampliﬁcation, CDCA7 exhibits high expression in various tumors and is correlated with unfavorable prognosis [8, 9] . CDCA7 promotes tumor cell  \nproliferation, invasion, and metastasis in various cancers, including esophageal, gastric, and ovarian cancers, and regulates malignant biological processes, including inﬂammatory factors [10–12] . CDCA7 is a drug resistance-associated cell cycle protein that is highly expressed in paclitaxel-resistant subgroup of non-small cell lung cancer [13, 14] . However, the precise role of CDCA7 in PC progression remains unclear.  \nRecently, the role of metabolic reprogramming in the development of drug resistance in PC has attracted considerable attention [15] . Research ﬁndings indicate that stroma formation and the complex tumor microenvironment, including aberrant glycolytic metabolism reprogramming, are crucial factors contributing to chemo","cbCaikC0adXEz3hz","https://ap.wps.com/l/cbCaikC0adXEz3hz","pdf",12530265,12,"English","# Introduction\n## Pancreatic cancer challenge and gemcitabine resistance\n## CDCA7 roles in cancer and drug resistance\n## Metabolic reprogramming in chemotherapy resistance\n## STAT3 signaling background","[{\"question\":\"What question does the study aim to address about CDCA7 in pancreatic cancer?\",\"answer\":\"It examines CDCA7 expression and its biological functions in pancreatic cancer, particularly whether it contributes to progression and gemcitabine resistance.\"},{\"question\":\"How is CDCA7 shown to affect pancreatic cancer cell behavior?\",\"answer\":\"CDCA7 overexpression promotes proliferation, migration, invasion, and wound healing in pancreatic cancer models.\"},{\"question\":\"What mechanism links CDCA7 to gemcitabine resistance in this research?\",\"answer\":\"The study reports that CDCA7 increases aerobic glycolysis and interacts with STAT3, affecting transcriptional regulation of hexokinase 2, which may drive gemcitabine resistance.\"}]","CDCA7 enhances STAT3 transcriptional activity to regulate aerobic glycolysis and promote pancreatic cancer progression and gemcitabine resistance | PDF",1790187594,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1efd1fc45706677f9fea35de785eeea6.webp",983,1305,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1ca493102b78b6716c4bd3fe0c3dd632.webp",982,1304,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c5103c21f0e0010486653d36dd5d8d3a.webp",981,1303,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e06df12f6e210808a5624a010b4f1445.webp",980,1301]